PNC Financial Services Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $591K | Sell |
|
|||||
|
2025
Q1 | $906K | Buy |
|
|||||
|
2024
Q4 | $800K | Buy |
|
|||||
|
2024
Q3 | $850K | Buy |
|
|||||
|
2024
Q2 | $738K | Buy |
|
|||||
|
2024
Q1 | $657K | Sell |
|
|||||
|
2023
Q4 | $791K | Sell |
|
|||||
|
2023
Q3 | $736K | Sell |
|
|||||
|
2023
Q2 | $852K | Sell |
|
|||||
|
2023
Q1 | $1.07M | Sell |
|
|||||
|
2022
Q4 | $1.16M | Sell |
|
|||||
|
2022
Q3 | $986K | Buy |
|
|||||
|
2022
Q2 | $898K | Buy |
|
|||||
|
2022
Q1 | $644K | Buy |
|
|||||
|
2021
Q4 | $645K | Sell |
|
|||||
|
2021
Q3 | $584K | Buy |
|
|||||
|
2021
Q2 | $557K | Buy |
|
|||||
|
2021
Q1 | $482K | Sell |
|
|||||
|
2020
Q4 | $756K | Buy |
|
|||||
|
2020
Q3 | $469K | Sell |
|
|||||
|
2020
Q2 | $772K | Sell |
|
|||||
|
2020
Q1 | $577K | Buy |
|
|||||
|
2019
Q4 | $483K | Sell |
|
|||||
|
2019
Q3 | $2.09M | Sell |
|
|||||
|
2019
Q2 | $3.05M | Sell |
|
|||||
|
2019
Q1 | $3.38M | Sell |
|
|||||
|
2018
Q4 | $3.53M | Sell |
|
|||||
|
2018
Q3 | $4.03M | Sell |
|
|||||
|
2018
Q2 | $4.06M | Buy |
|
|||||
|
2018
Q1 | $3.42M | Buy |
|
|||||
|
2017
Q4 | $3.69M | Sell |
|
|||||
|
2017
Q3 | $3.98M | Sell |
|
|||||
|
2017
Q2 | $3.95M | Buy |
|
|||||
|
2017
Q1 | $3.65M | Sell |
|
|||||
|
2016
Q4 | $3.77M | Sell |
|
|||||
|
2016
Q3 | $4.68M | Buy |
|
|||||
|
2016
Q2 | $3.67M | Sell |
|
|||||
|
2016
Q1 | $4.33M | Buy |
|
|||||
|
2015
Q4 | $4.75M | Sell |
|
|||||
|
2015
Q3 | $5.14M | Buy |
|
|||||
|
2015
Q2 | $6.56M | Sell |
|
|||||
|
2015
Q1 | $6.03M | Sell |
|
|||||
|
2014
Q4 | $4.48M | Buy |
|
|||||
|
2014
Q3 | $3.56M | Buy |
|
|||||
|
2014
Q2 | $2.91M | Buy |
|
|||||
|
2014
Q1 | $2.68M | Sell |
|
|||||
|
2013
Q4 | $2.85M | Sell |
|
|||||
|
2013
Q3 | $2.92M | Sell |
|
|||||
|
2013
Q2 | $2.45M | Buy |
|